But individual response varies
Leonard Glass, senior vice president global medical affairs, Lilly Diabetes and Obesity
In current study, we used newly developed monoclonal antibody that has previously been validated as specific for GLP-1R [24] and demonstrated that the protein levels of GLP-1Rs in the pelvis are greater in HF than Sham, suggesting that enhanced expression of GLP-1R in the pelvis leads to enhanced activation of afferent renal nerves in rats with HF
They slow down how quickly your stomach empties, signal your brain to curb cravings, and boost insulin production while reducing unnecessary glucose output
Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist
Jean Molinary, Endocrinology, Diabetes & Metabolism 19